Among those, PNPLA3 and GCKR SNPs were shown to be the main variants, interacting with insulin, IR, levels of TG, and glucose to increase NAFLD risk in non-diabetic individuals [202]. Here, PNPLA3 is linked to metabolic dysfunction-associated steatotic liver disease.